Molecular Therapies; Dr. David Segal

Is it possible to “turn on” or express the UBE3A gene? Dr. David Segal from the University of California Davis talks about the FIRE funded project his laboratory is undertaking to design proteins that can bind to DNA and “turn on” or “turn off” the expression of specific genes. Learn about targeted gene expression therapy and it's applications in Angelman Syndrome. Read more here...